VitaGen


VitaGen Incorporated, a biotechnology and medical products company, developed one of a external artificial human livers. The ELAD (Extracorporeal Liver Assist Device) Artificial Liver is a two-chambered hollow-fiber cartridge containing a cultured human liver cell line (C3A). The ELAD intends either to provide short term hepatic replacement therapy for patients with acute liver failure until their own liver can regenerate or to sustain patients until a transplant organ is available and offer pos...Show all

VitaGen Incorporated, a biotechnology and medical products company, developed one of a external artificial human livers. The ELAD (Extracorporeal Liver Assist Device) Artificial Liver is a two-chambered hollow-fiber cartridge containing a cultured hu...Show all

Company (Acquired)

Phone: 858-552-1522

Fax:

3344 N. Torrey Pines Court Suite 100
La Jolla, 92037
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
VitaGen $29.9M Oct 17, 2003
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related VitaGen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 17 investors

Competitors

Company Status Description Investors

Metabasis Therapeutics

La Jolla, California, United States
AcquiredBiopharmaceutical company developing products for diabetes, hepatitis, liver cancer, and other liver-related diseases.Login to see details

Threshold Pharmaceuticals

Redwood City, California, United States
MergedThreshold Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that offers broad potential to treat most solid tumors and certain other diseases. By selectively targeting tumor and certain other diseased cells, Threshold's pipeline of drug candidates holds promise to be more effective and less toxic to healthy tissues than conventional drugs. Threshold's initial clinical foc...Show allLogin to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)